Sight Sciences, Inc.
SGHT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001531177
In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 5 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $606.9M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $652.8K in total
- 5
- 13F holdersQ2 2026, 0 vs. previous quarter
- 112
- 13F valueReported value at the end of Q2 2026
- $118.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $77.4M
- −3.1% year over year
- Net income, FY2025
- -$38.4M
- No comparable prior period
- Free cash flow, FY2025
- -$29.9M
- No comparable prior period
- Revenue, Q3 FY2026
- $24.9M
- +25.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $38.4M (49.7% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.14M
- Shares sold short
- Change
- −105.3K
- −8.5% vs. previous
- Days to cover
- 4.31
- At average daily volume
Superinvestors holding SGHT, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding SGHT at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Sight Sciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 (view filing)4:43 PM ET | Oct 2 | 3 days | Taylor BrentonEVP, Operations & R&D | SSale | −2.99K | $8.85 | −$26.5K | −1.1%262.0K after | 10b5-1 |
| Oct 5, 2026 (view filing)4:43 PM ET | Oct 2 | 3 days | Bauerlein AlisonChief Operating Officer | SSale | −25.3K | $8.85 | −$223.6K | −3.8%639.4K after | 10b5-1 |
| Oct 5, 2026 (view filing)4:42 PM ET | Oct 2 | 3 days | Rodberg JamesChief Financial Officer | SSale | −7.21K | $8.85 | −$63.8K | −3.2%216.8K after | 10b5-1 |
| Oct 5, 2026 (view filing)4:40 PM ET | Oct 1 | 4 days | Badawi DavidChief Technology Officer | SSale | −7.80K | $9.05 | −$70.6K | −0.4%1.98M after | 10b5-1 |
| Oct 5, 2026 (view filing)4:40 PM ET | Oct 1 | 4 days | Badawi PaulPresident and CEO | SSale | −29.7K | $9.05 | −$268.3K | −0.5%6.09M after | 10b5-1 |
| Jul 6, 2026 (view filing)7:36 PM ET | Jul 6 | Same day | Hayden Jeremy B.Chief Legal Officer | SSale | −12.7K | $5.51 | −$70.1K | −3.4%357.0K after | 10b5-1 |
| Jul 6, 2026 (view filing)7:36 PM ET | Jul 2 | 4 days | Rodberg JamesChief Financial Officer | SSale | −6.90K | $5.36 | −$37.0K | −3.0%224.0K after | 10b5-1 |
| Jul 6, 2026 (view filing)7:34 PM ET | Jul 6 | Same day | Badawi DavidChief Technology Officer | SSale | −7.42K | $5.51 | −$40.9K | −0.4%1.98M after | 10b5-1 |
| Jul 6, 2026 (view filing)7:33 PM ET | Jul 1 | 5 days | Taylor BrentonEVP, Operations & R&D | SSale | −2.83K | $5.42 | −$15.3K | −1.1%265.0K after | 10b5-1 |
| Jul 6, 2026 (view filing)7:32 PM ET | Jul 2 | 4 days | Bauerlein AlisonChief Operating Officer | SSale | −24.2K | $5.36 | −$129.6K | −3.5%664.7K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 112 holdersThe largest institutional positions in Sight Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 3,844,100 | $20.8M | 0.85% | +250,000+7.0% | Added |
| BlackRock, Inc. | 3,083,108 | $16.7M | 0.00% | +251,176+8.9% | Added |
| Americana Partners, LLC | 1,679,069 | $9.10M | 0.20% | +520.0% | Added |
| Pathstone Holdings, LLC | 1,678,980 | $9.10M | 0.03% | −718,352−30.0% | Reduced |
| Vanguard Capital Management LLC | 1,573,815 | $8.53M | 0.00% | +121,125+8.3% | Added |
| Geode Capital Management, LLC | 958,565 | $5.20M | 0.00% | +43,121+4.7% | Added |
| State Street Corp | 835,452 | $4.53M | 0.00% | +424+0.1% | Added |
| Acadian Asset Management LLC | 806,576 | $4.36M | 0.01% | +35,643+4.6% | Added |
| B Group, Inc. | 970,000 | $3.66M | 2.08% | 00.0% | Unchanged |
| AQR Capital Management LLC | 397,558 | $2.15M | 0.00% | +259,041+187.0% | Added |
Holders of 5% or more of SGHT
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Sight Sciences, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Encrantz Staffan | 13D/A | 13.10%6.73M shares | – | Dec 10, 20214 filings | Mar 13, 2025 | SEC |
| Long Focus Capital Management, LLC | 13G/A | 6.00%3.13M shares | +1.00 ppfrom 5.00% | Jan 23, 20252 filings | May 15, 2025 | SEC |
| BlackRock, Inc. | 13G | 5.01%2.65M shares | New | Jan 21, 20261 filing | Jan 21, 2026 | SEC |